Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Pancreatitis

  Free Subscription


Articles published in Ann Surg

Retrieve available abstracts of 122 articles:
HTML format



Single Articles


    March 2022
  1. YAMAGUCHI J, Yokoyama Y, Fujii T, Yamada S, et al
    Results of a Phase II Study on the use of Neoadjuvant Chemotherapy (FOLFIRINOX or Gemcitabine with nab-paclitaxel) for Borderline-Resectable Pancreatic Cancer (NUPAT-01).
    Ann Surg. 2022 Mar 3. pii: 00000658-900000000-93060.
    PubMed     Abstract available


  2. DA COSTA WL JR, Tran Cao HS, Gu X, Massarweh NN, et al
    Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma.
    Ann Surg. 2022;275:415-421.
    PubMed     Abstract available


  3. SCHULICK RD
    Commentary on "Laparoscopic Pancreaticoduodenectomy With Transanal Specimen Extraction for Periampullary Tumors".
    Ann Surg. 2022;275:e599.
    PubMed    


    February 2022
  4. BOECK S, Heinemann V, Werner J
    Comment on "Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis".
    Ann Surg. 2022 Feb 1. pii: 00000658-900000000-93084.
    PubMed    


  5. DAAMEN LA, Groot VP, Verkooijen HM, Molenaar IQ, et al
    Response to: Comment on "Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis".
    Ann Surg. 2022 Feb 1. pii: 00000658-900000000-93083.
    PubMed    


    January 2022
  6. JAVED AA, Pulvirenti A, Razi S, Zheng J, et al
    Grading Pancreatic Neuroendocrine Tumors via Endoscopic Ultrasound-guided Fine Needle Aspiration: A Multi-Institutional Study.
    Ann Surg. 2022 Jan 25. pii: 00000658-900000000-93105.
    PubMed     Abstract available


  7. OMIYA K, Oba A, Inoue Y, Kobayashi K, et al
    Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Non-secretors with Pancreatic Cancer.
    Ann Surg. 2022 Jan 25. pii: 00000658-900000000-93098.
    PubMed     Abstract available



  8. Root-cause Analysis of Mortality After Pancreatic Resection (CARE Study): A Multicenter Cohort Study: Erratum.
    Ann Surg. 2022;275:e280.
    PubMed    


    December 2021
  9. JANSSEN BV, Verhoef S, Wesdorp NJ, Huiskens J, et al
    Imaging-based Machine-learning Models to Predict Clinical Outcomes and Identify Biomarkers in Pancreatic Cancer: A Scoping Review.
    Ann Surg. 2021 Dec 23. pii: 00000658-900000000-93137.
    PubMed     Abstract available


  10. LOPEZ-VERDUGO F, Fong ZV, Lillemoe KD, Blaszkowsky LS, et al
    Underlying Bias in the Treatment of Pancreatic Cancer: Minorities Treated at the Same Facilities are Less Likely to Receive Neoadjuvant Therapy.
    Ann Surg. 2021 Dec 23. pii: 00000658-900000000-93135.
    PubMed     Abstract available


  11. NAGAKAWA Y, Jang JY, Kawai M, Kim SC, et al
    Surgical Outcomes of Pancreatectomy with Resection of the Portal Vein and/or Superior Mesenteric Vein and Jejunal Vein for Pancreatic Head Cancer: A Multicenter Study.
    Ann Surg. 2021 Dec 14. pii: 00000658-900000000-93153.
    PubMed     Abstract available


  12. CLARKE CN, Maduekwe UN
    Commentary on Brief Clinical Report: "Coronary Artery Stent for Securing High-risk Pancreatico-jejunal Anastomosis After Pancreaticoduodenectomy: A pilot series".
    Ann Surg. 2021 Dec 14. pii: 00000658-900000000-93145.
    PubMed    


  13. HUANG L, Jansen L, Balavarca Y, van der Geest L, et al
    Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study.
    Ann Surg. 2021;274:e554-e563.
    PubMed     Abstract available


    November 2021
  14. BEDNAR F
    Clinical Staging Uncertainty and Treatment Sequencing in Pancreatic Cancer.
    Ann Surg. 2021 Nov 18. pii: 00000658-900000000-93186.
    PubMed    


  15. HUSCHER C, Perri G, Lazzarin G, Marchegiani G, et al
    Coronary Artery Stent for Securing High-risk Pancreatico-jejunal Anastomosis After Pancreatoduodenectomy: A Pilot Series.
    Ann Surg. 2021 Nov 18. pii: 00000658-900000000-93185.
    PubMed     Abstract available


  16. GARAJOVA I, Balsano R, Donati V, Gnetti L, et al
    Comment on "Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma by Crippa et al."
    Ann Surg. 2021 Nov 11. pii: 00000658-900000000-93189.
    PubMed    


  17. DAYYEH BKA, Chandrasekhara V, Shah RJ, Easler JJ, et al
    Combined Drainage and Protocolized Necrosectomy Through a Co-axial Lumen-Apposing Metal Stent for Pancreatic Walled-off Necrosis: A Prospective Multicenter Trial.
    Ann Surg. 2021 Nov 2. pii: 00000658-900000000-93212.
    PubMed     Abstract available


    October 2021
  18. KEMPENEERS MA, Issa Y, Bruno MJ, van Santvoort HC, et al
    Cost-Effectiveness of Early Surgery Versus Endoscopy-First Approach for Painful Chronic Pancreatitis in the ESCAPE Trial.
    Ann Surg. 2021 Oct 8. pii: 00000658-900000000-93237.
    PubMed     Abstract available


  19. DALMACY D, Paro A, Hyer JM, Obeng-Gyasi S, et al
    Association of County-level Upward Economic Mobility with Stage at Diagnosis and Receipt of Treatment Among Patients Diagnosed with Pancreatic Adenocarcinoma.
    Ann Surg. 2021 Oct 8. pii: 00000658-900000000-93235.
    PubMed     Abstract available


    September 2021
  20. MARCHEGIANI G, Barreto SG, Bannone E, Sarr M, et al
    Postpancreatectomy Acute Pancreatitis (PPAP): Definition and Grading from the International Study Group for Pancreatic Surgery (ISGPS).
    Ann Surg. 2021 Sep 29. pii: 00000658-900000000-93261.
    PubMed     Abstract available


    August 2021
  21. LIU Q, Zhao Z, Zhang X, Wang W, et al
    Perioperative and Oncological Outcomes of Robotic Versus Open Pancreaticoduodenectomy in Low-Risk Surgical Candidates: A Multicenter Propensity Score-Matched Study.
    Ann Surg. 2021 Aug 19. pii: 00000658-900000000-93318.
    PubMed     Abstract available


  22. ROLDAN J, Harrison JM, Qadan M, Bolm L, et al
    "Evolving Trends in Pancreatic Cystic Tumors: A 3-Decade Single-Center Experience with 1290 Resections".
    Ann Surg. 2021 Aug 4. pii: 00000658-900000000-93359.
    PubMed     Abstract available


    July 2021
  23. BIRRER DL, Golcher H, Casadei R, Haile SR, et al
    Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data from Three Randomized Controlled Trials.
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93387.
    PubMed     Abstract available


  24. BEUGNIEZ C, Sauvanet A, Sulpice L, Gaujoux S, et al
    Root-Cause Analysis of Mortality Following Pancreatic Resection (CARE Study): A Multicenter Cohort Study.
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93374.
    PubMed     Abstract available


  25. BRADA LJH, Daamen LA, Magermans LG, Walma MS, et al
    Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer Following Upfront FOLFIRINOX versus FOLFIRINOX Only: Multicenter Propensity Score-Matched Analysis.
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93372.
    PubMed     Abstract available


  26. JOLISSAINT JS, Reyngold M, Bassmann J, Seier KP, et al
    Local Control and Survival after Induction Chemotherapy and Ablative Radiation Versus Resection for Pancreatic Ductal Adenocarcinoma with Vascular Involvement.
    Ann Surg. 2021 Jul 16. pii: 00000658-900000000-93409.
    PubMed     Abstract available


  27. MAATMAN TK, McGuire SP, Flick KF, Madison MK, et al
    Outcomes in Endoscopic and Operative Transgastric Pancreatic Debridement.
    Ann Surg. 2021 Jul 7. pii: 00000658-900000000-93434.
    PubMed     Abstract available


  28. YEO TP, Fogg RW, Shimada A, Marchesani N, et al
    The Imperative of Assessing Quality of Life in Patients Presenting to a Pancreaticobiliary Surgery Clinic.
    Ann Surg. 2021 Jul 2. pii: 00000658-900000000-93452.
    PubMed     Abstract available


  29. BLAIR AB, Yin LD, Pu N, Yu J, et al
    Recurrence in Patients Achieving Pathological Complete Response After Neoadjuvant Treatment for Advanced Pancreatic Cancer.
    Ann Surg. 2021;274:162-169.
    PubMed     Abstract available


    June 2021
  30. HESTER CA, Kothari AN, Mason M, Maxwell J, et al
    Surgical Eligibility Does Not Imply Surgical Equity: Recommendations for Curative Treatment in Patients with Stage I/II Pancreatic Head Adenocarcinoma Differ by Age and Race.
    Ann Surg. 2021 Jun 25. pii: 00000658-900000000-93456.
    PubMed     Abstract available


  31. DAI M, Liu Q, Xing C, Tian X, et al
    Early Drain Removal is Safe in Patients With Low or Intermediate Risk of Pancreatic Fistula After Pancreaticoduodenectomy: A Multicenter, Randomized Controlled Trial.
    Ann Surg. 2021 Jun 11. pii: 00000658-900000000-93510.
    PubMed     Abstract available


    April 2021
  32. BANNONE E, Marchegiani G, Balduzzi A, Procida G, et al
    Early and Sustained Elevation in Serum Pancreatic Amylase Activity: A Novel Predictor of Morbidity after Pancreatic Surgery.
    Ann Surg. 2021 Apr 30. pii: 00000658-900000000-93565.
    PubMed     Abstract available


  33. GIULIANI T, De Pastena M, Paiella S, Marchegiani G, et al
    Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis.
    Ann Surg. 2021 Apr 14. pii: 00000658-900000000-93588.
    PubMed     Abstract available


  34. HABIB JR, Kinny-Koster B, Bou-Samra P, Alsaad R, et al
    Surgical Decision Making in Pancreatic Ductal Adenocarcinoma: Modeling Prognosis Following Pancreatectomy in the Era of Induction and Neoadjuvant Chemotherapy.
    Ann Surg. 2021 Apr 9. pii: 00000658-900000000-93602.
    PubMed     Abstract available


  35. MENG H, Wang S, Liu J, Zhao X, et al
    Laparoscopic Pancreaticoduodenectomy with Transanal Specimen Extraction for Periampullary Tumors.
    Ann Surg. 2021 Apr 7. pii: 00000658-900000000-93576.
    PubMed     Abstract available


  36. HACKERT T, Buchler MW
    Respone to: Comment on Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004872.
    PubMed    


  37. LINDEMANN J, Toit LD, Krige J, Jonas E, et al
    Comment on: Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004877.
    PubMed    


    March 2021
  38. SCHUH F, Mihaljevic AL, Probst P, Trudeau MT, et al
    A Simple Classification Of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: A classification of the International Study Group of Pancreatic Surgery (ISGPS).
    Ann Surg. 2021 Mar 12. doi: 10.1097/SLA.0000000000004855.
    PubMed     Abstract available


  39. MARCHEGIANI G, Perri G, Burelli A, Zoccatelli F, et al
    High-risk Pancreatic Anastomosis vs. Total Pancreatectomy after Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis.
    Ann Surg. 2021 Mar 4. doi: 10.1097/SLA.0000000000004840.
    PubMed     Abstract available


  40. HANK T, Hinz U, Reiner T, Malleo G, et al
    A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer.
    Ann Surg. 2021 Mar 4. doi: 10.1097/SLA.0000000000004845.
    PubMed     Abstract available


    February 2021
  41. LOOS M, Hackert T, Buchler MW
    Response to Comment on "Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93709.
    PubMed    


  42. REAMES BN, Ejaz A, Weiss MJ
    Comment on "Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93707.
    PubMed    


    January 2021
  43. BEGER HG, Mayer B, Vasilescu C, Poch B, et al
    Long-term Metabolic Morbidity and Steatohepatosis Following Standard Pancreatic Resections and Parenchyma-sparing, Local Extirpations for Benign Tumor: A Systematic Review and Meta-analysis.
    Ann Surg. 2021 Jan 15. doi: 10.1097/SLA.0000000000004757.
    PubMed     Abstract available


  44. VAN DEN BERG FF, Issa Y, Vreijling JP, Lerch MM, et al
    Whole-Exome Sequencing Identifies SLC52A1 and ZNF106 Variants as Novel Genetic Risk Factors for (Early) Multiple-Organ Failure in Acute Pancreatitis.
    Ann Surg. 2021;Publish Ahead of Print.
    PubMed     Abstract available


  45. ADDEO P, Averous G, Bachellier P
    Response to Comment on "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?"
    Ann Surg. 2021 Jan 1. pii: 00000658-900000000-93782.
    PubMed    


    December 2020
  46. QING Z, Liu ZY, Chen QY, Huang CM, et al
    Comment on: Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers.
    Ann Surg. 2020 Dec 29. doi: 10.1097/SLA.0000000000004734.
    PubMed    


  47. HEWITT DB, Nissen N, Hatoum H, Musher B, et al
    A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects with Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer.
    Ann Surg. 2020 Dec 22. doi: 10.1097/SLA.0000000000004669.
    PubMed     Abstract available


  48. GIBOR U, Perry Z, Netz U, Kirshtein B, et al
    Circulating Cell-free DNA in Patients with Acute Biliary Pancreatitis: Association with Disease Markers and Prolonged Hospitalization Time-A Prospective Cohort Study.
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  49. SUGUMAR K, Hue JJ, Ahorukomeye P, Rothermel LD, et al
    Defining Common Features in High Impact and Highly Cited Journal Articles on Pancreatic Tumors: An Analysis of 1044 Studies over the Past Decade.
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  50. DE GEUS SWL, Hachey KJ, Nudel JD, Ng SC, et al
    Volume of Pancreas-Adjacent Operations Favorably Influences Pancreaticoduodenectomy Outcomes at Lower Volume Pancreas Centers.
    Ann Surg. 2020 Dec 2. doi: 10.1097/SLA.0000000000004432.
    PubMed     Abstract available


  51. VERSTEIJNE E, Suker M, Groen JV, Besselink MG, et al
    External Validity of the Multicenter Randomized PREOPANC Trial on Neoadjuvant Chemoradiotherapy in Pancreatic Cancer: Outcome of Eligible But Non-Randomized Patients.
    Ann Surg. 2020 Dec 2. doi: 10.1097/SLA.0000000000004364.
    PubMed     Abstract available


    November 2020
  52. HUNGER R, Mantke R
    Outcome Quality Beyond the Mean - An Analysis of 43,231 Pancreatic Surgical Procedures Related to Hospital Volume.
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004315.
    PubMed     Abstract available


  53. LOF S, Korrel M, Besselink MG, Abu Hilal M, et al
    Response to Comment on "Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004279.
    PubMed    


  54. CHEN B, Li G, Cheng W, Chen M, et al
    Comment On: Colon Involvement in Necrotizing Pancreatitis: Incidence, Risk Factors, and Outcomes.
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004621.
    PubMed    


  55. ZYROMSKI NJ, Maatman TK
    Response to Letter to Editor Regarding: "Colon Involvement in Necrotizing Pancreatitis: Incidence, Risk Factors, and Outcomes" (Ann Surg 2020 Jul 7. Online Ahead of Print; PMID: 32649468).
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004622.
    PubMed    


  56. ROBERTSON FP, Ravikumar R, Wigmore SJ
    Comment on: Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004536.
    PubMed    


  57. ZHANG XP, Zhao GD, Liu R
    Comment On "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?"
    Ann Surg. 2020 Nov 16. doi: 10.1097/SLA.0000000000004410.
    PubMed    


  58. RAMIREZ-MALDONADO E, Gordo SL, Pueyo EM, Sanchez-Garcia A, et al
    Immediate Oral Refeeding in Patients With Mild and Moderate Acute Pancreatitis: A Multicenter, Randomized Controlled Trial (PADI trial).
    Ann Surg. 2020 Nov 13. doi: 10.1097/SLA.0000000000004596.
    PubMed     Abstract available


  59. VAN DONGEN JC, Suker M, Versteijne E, Bonsing BA, et al
    Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial).
    Ann Surg. 2020 Nov 12. doi: 10.1097/SLA.0000000000004313.
    PubMed     Abstract available


  60. MALLEO G, Maggino L, Qadan M, Marchegiani G, et al
    Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2020 Nov 9. doi: 10.1097/SLA.0000000000004552.
    PubMed     Abstract available


    October 2020
  61. HUANG L
    Response to the: Comment on "Optimal Number of Examined Lymph Node May Depend on Age in Patients with Pancreatic Adenocarcinoma".
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004449.
    PubMed    


  62. CRIPPA S, Pergolini I, Javed AA, Honselmann KC, et al
    Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004464.
    PubMed     Abstract available


  63. DATTA J, Wilson GC, D'Angelica MI, Katz MH, et al
    A Call for Caution in Overinterpreting Exceptional Outcomes Following Radical Surgery for Pancreatic Cancer: Let the Data Speak.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004471.
    PubMed    


  64. MAATMAN TK, Ceppa EP, Fogel EL, Easler JJ, et al
    Biliary Stricture after Necrotizing Pancreatitis: An Underappreciated Challenge.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004470.
    PubMed     Abstract available


  65. CHAWLA A, Qadan M, Castillo CF, Wo JY, et al
    Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004585.
    PubMed     Abstract available


  66. XU HX, Li S, Xu SS, Liu L, et al
    Comments on "Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients with Localized Pancreatic Cancer".
    Ann Surg. 2020 Oct 15. doi: 10.1097/SLA.0000000000004538.
    PubMed    


  67. TAKAHASHI S, Ohno I, Ikeda M, Konishi M, et al
    Neoadjuvant S-1 With Concurrent Radiotherapy Followed by Surgery for Borderline Resectable Pancreatic Cancer: A Phase II Open-Label Multicenter Prospective Trial (JASPAC05).
    Ann Surg. 2020 Oct 15. doi: 10.1097/SLA.0000000000004535.
    PubMed     Abstract available


  68. SCHULICK RD, Oba A, Del Chiaro M
    Response to the Comment on "Prognosis-based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines".
    Ann Surg. 2020 Oct 14. doi: 10.1097/SLA.0000000000004275.
    PubMed    


    September 2020
  69. HU HJ, Cheng NS, Li FY
    Comment on: Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study.
    Ann Surg. 2020 Sep 29. doi: 10.1097/SLA.0000000000004283.
    PubMed    


    August 2020
  70. WUSTER C, Shi H, Kuhlbrey CM, Biesel EA, et al
    Pancreatic Inflammation and Proenzyme Activation Are Associated With Clinically Relevant Postoperative Pancreatic Fistulas After Pancreas Resection.
    Ann Surg. 2020 Aug 21. doi: 10.1097/SLA.0000000000004257.
    PubMed     Abstract available


  71. TAKAI E, Nakamura H, Chiku S, Kubo E, et al
    Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer.
    Ann Surg. 2020 Aug 18. doi: 10.1097/SLA.0000000000004213.
    PubMed     Abstract available


  72. DREYER SB, Pinese M, Jamieson NB, Scarlett CJ, et al
    Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer.
    Ann Surg. 2020;272:366-376.
    PubMed     Abstract available


  73. HONSELMANN KC, Pergolini I, Castillo CF, Deshpande V, et al
    Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer.
    Ann Surg. 2020;272:357-365.
    PubMed     Abstract available


  74. OBA A, Stoop TF, Lohr M, Hackert T, et al
    Global Survey on Pancreatic Surgery During the COVID-19 Pandemic.
    Ann Surg. 2020;272:e87-e93.
    PubMed     Abstract available


    July 2020
  75. KATO H, Kishiwada M, Hayasaki A, Chipaila J, et al
    Role of Serum Carcinoma Embryonic Antigen (CEA) Level in Localized Pancreatic Adenocarcinoma: CEA Level Before Operation is a Significant Prognostic Indicator in Patients With Locally Advanced Pancreatic Cancer Treated With Neoadjuvant Therapy Followe
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004148.
    PubMed     Abstract available


  76. WEI MY, Hua J, Yu XJ, Shi S, et al
    Comment on "Prognosis-Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines".
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004291.
    PubMed    


  77. KONE LB, Torres C, Banulescu M, Maker VK, et al
    Perioperative Broad-spectrum Antibiotics are Associated With Decreased Surgical Site Infections Compared to 1st-3rd Generation Cephalosporins After Open Pancreaticoduodenectomy in Patients With Jaundice or a Biliary Stent.
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004216.
    PubMed     Abstract available


  78. ARRINGTON AK, O'Grady C, Schaefer K, Khreiss M, et al
    Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers.
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004181.
    PubMed     Abstract available


  79. AHMAD SA, Duong M, Sohal DPS, Gandhi NS, et al
    Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004155.
    PubMed     Abstract available


  80. MERCHANT N
    Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer.
    Ann Surg. 2020 Jul 16. doi: 10.1097/SLA.0000000000004191.
    PubMed    


  81. SEPPALA TT, Zimmerman JW, Sereni E, Plenker D, et al
    Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer.
    Ann Surg. 2020 Jul 9. doi: 10.1097/SLA.0000000000004200.
    PubMed     Abstract available


  82. EVANS DB
    The Complexity of Neoadjuvant Therapy for Operable Pancreatic Cancer: Lessons Learned From SWOG S1505.
    Ann Surg. 2020 Jul 9. doi: 10.1097/SLA.0000000000004131.
    PubMed    


  83. DAAMEN LA, Groot VP, Besselink MG, Bosscha K, et al
    Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis.
    Ann Surg. 2020 Jul 8. doi: 10.1097/SLA.0000000000004093.
    PubMed     Abstract available


  84. POULTSIDES GA
    Pancreatic Cancer Prognostication: From Trousseau to Thrombelastography.
    Ann Surg. 2020 Jul 8. doi: 10.1097/SLA.0000000000004139.
    PubMed    


  85. STROBEL O, Lorenz P, Hinz U, Gaida M, et al
    Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma: Who Beats the Odds?
    Ann Surg. 2020 Jul 7. doi: 10.1097/SLA.0000000000004147.
    PubMed     Abstract available


  86. MAATMAN TK, Nicolas ME, Roch AM, Lewellen KA, et al
    Colon Involvement in Necrotizing Pancreatitis: Incidence, Risk Factors, and Outcomes.
    Ann Surg. 2020 Jul 7. doi: 10.1097/SLA.0000000000004149.
    PubMed     Abstract available


  87. ROTH S, Bose P, Alhamdani MSS, Mustafa SA, et al
    Noninvasive Discrimination of Low and High-risk Pancreatic Intraductal Papillary Mucinous Neoplasms.
    Ann Surg. 2020 Jul 7. doi: 10.1097/SLA.0000000000004066.
    PubMed     Abstract available


  88. HANK T, Sandini M, Ferrone CR, Ryan DP, et al
    A Combination of Biochemical and Pathological Parameters Improves Prediction of Postresection Survival After Preoperative Chemotherapy in Pancreatic Cancer: The PANAMA-score.
    Ann Surg. 2020 Jul 7. doi: 10.1097/SLA.0000000000004143.
    PubMed     Abstract available


    June 2020
  89. LOOS M, Kester T, Klaiber U, Mihaljevic AL, et al
    Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve.
    Ann Surg. 2020 Jun 12. doi: 10.1097/SLA.0000000000004054.
    PubMed     Abstract available


  90. TRUDEAU MT, Casciani F, Ecker BL, Maggino L, et al
    The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy.
    Ann Surg. 2020 Jun 11. doi: 10.1097/SLA.0000000000004068.
    PubMed     Abstract available


  91. ZHANG XF, Xue F, Wu Z, Lopez-Aguiar AG, et al
    Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors.
    Ann Surg. 2020 Jun 4. doi: 10.1097/SLA.0000000000004039.
    PubMed     Abstract available


  92. NEYTON LPA, Zheng X, Skouras C, Doeschl-Wilson A, et al
    Molecular Patterns in Acute Pancreatitis Reflect Generalizable Endotypes of the Host Response to Systemic Injury in Humans.
    Ann Surg. 2020 Jun 2. doi: 10.1097/SLA.0000000000003974.
    PubMed     Abstract available


  93. FERRONE CR, Ryan DP
    Pancreatic Cancer: A Time to Change.
    Ann Surg. 2020;271:1003-1004.
    PubMed    


    May 2020
  94. ZHANG YY, Xu J, Yu XJ, Shi S, et al
    Comment on "Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma".
    Ann Surg. 2020 May 29. doi: 10.1097/SLA.0000000000003989.
    PubMed    


  95. PERRI G, Katz MHG
    Response to the Comment on "Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma".
    Ann Surg. 2020 May 11. doi: 10.1097/SLA.0000000000003987.
    PubMed    


  96. KANDIMALLA R, Shimura T, Mallik S, Sonohara F, et al
    Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2020 May 8. doi: 10.1097/SLA.0000000000003945.
    PubMed     Abstract available


  97. OBA A, Stoop TF, Lohr M, Hackert T, et al
    Global Survey on Pancreatic Surgery During the COVID-19 Pandemic.
    Ann Surg. 2020 May 1. doi: 10.1097/SLA.0000000000004006.
    PubMed    


    April 2020
  98. HACKERT T, Klaiber U, Hinz U, Buchler MW, et al
    Response to the Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer".
    Ann Surg. 2020;271:e109-e110.
    PubMed    


    March 2020
  99. ZHENG ZJ, Chen YH, Tan CL, Liu XB, et al
    Comment on "Optimal Number of Examined Lymph Node May Dependent on Age in Patients With Pancreatic Adenocarcinoma".
    Ann Surg. 2020 Mar 20. doi: 10.1097/SLA.0000000000003811.
    PubMed    


  100. HUA J, Shi S, Xu J, Wei M, et al
    Expression Patterns and Prognostic Value of DNA Damage Repair Proteins in Resected Pancreatic Neuroendocrine Neoplasms.
    Ann Surg. 2020 Mar 20. doi: 10.1097/SLA.0000000000003884.
    PubMed     Abstract available


  101. OBA A, Croce C, Hosokawa P, Meguid C, et al
    Prognosis Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines.
    Ann Surg. 2020 Mar 6. doi: 10.1097/SLA.0000000000003859.
    PubMed     Abstract available


    February 2020
  102. STRIJKER M, Mackay TM, Bonsing BA, Bruno MJ, et al
    Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cancer Group.
    Ann Surg. 2020 Feb 20. doi: 10.1097/SLA.0000000000003779.
    PubMed    


    January 2020
  103. KLEIN HJ, Niggemann P, Buehler PK, Lehner F, et al
    Pancreatic Stone Protein Predicts Sepsis in Severely Burned Patients Irrespective of Trauma Severity: A Monocentric Observational Study.
    Ann Surg. 2020 Jan 14. doi: 10.1097/SLA.0000000000003784.
    PubMed     Abstract available


  104. RICCI C, Pagano N, Ingaldi C, Frazzoni L, et al
    Treatment for Infected Pancreatic Necrosis Should be Delayed, Possibly Avoiding an Open Surgical Approach: A Systematic Review and Network Meta-analysis.
    Ann Surg. 2020 Jan 14. doi: 10.1097/SLA.0000000000003767.
    PubMed     Abstract available


  105. MOAVEN O, Clark CJ, Russell GB, Votanopoulos KI, et al
    Optimal Adjuvant Treatment Approach After Upfront Resection of Pancreatic Cancer: Revisiting the Role of Radiation Based on Pathologic Features.
    Ann Surg. 2020 Jan 6. doi: 10.1097/SLA.0000000000003770.
    PubMed     Abstract available


    December 2019
  106. PERRI G, Prakash L, Qiao W, Varadhachary GR, et al
    Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma.
    Ann Surg. 2019 Dec 31. doi: 10.1097/SLA.0000000000003763.
    PubMed     Abstract available


  107. LOF S, Korrel M, van Hilst J, Moekotte AL, et al
    Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study.
    Ann Surg. 2019 Dec 10. doi: 10.1097/SLA.0000000000003717.
    PubMed     Abstract available


  108. REN W, Ashley SW
    Comment on Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Ann Surg. 2019 Dec 5. doi: 10.1097/SLA.0000000000003667.
    PubMed    


  109. BALZANO G, Pecorelli N, Falconi M, Reni M, et al
    Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer" What Is Good for the Surgeon Is Just as Good for the Patient?
    Ann Surg. 2019 Dec 5. doi: 10.1097/SLA.0000000000003655.
    PubMed    


  110. POWERS BD, Fulp W, Dhahri A, DePeralta DK, et al
    The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Center: A Retrospective Cohort Analysis.
    Ann Surg. 2019 Dec 5. doi: 10.1097/SLA.0000000000003706.
    PubMed     Abstract available


  111. ZHANG B, Lee GC, Qadan M, Fong ZV, et al
    Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma.
    Ann Surg. 2019 Dec 5. doi: 10.1097/SLA.0000000000003503.
    PubMed     Abstract available


  112. RANGELOVA E, Orsini N, Del Chiaro M
    Response to Comment on "Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer".
    Ann Surg. 2019;270:e139-e141.
    PubMed    


  113. HUA J, Shi S, Yu X
    Comment on "Operable Pancreatic Cancer: Are We in an Era of Individualized Neoadjuvant Therapy?"
    Ann Surg. 2019;270:e94-e95.
    PubMed    


  114. DOKMAK S
    Comment on "Comparison of Perioperative Outcomes Between the Laparoscopic and Open Approach for Pancreaticoduodenectomy: Can We Compare the Results of the Laparoscopic Approach With Bad Results of the Open Approach?"
    Ann Surg. 2019;270:e91-e92.
    PubMed    


    October 2019
  115. BEANE JD, Borrebach JD, Zureikat AH, Kilbane EM, et al
    Optimal Pancreatic Surgery: Are We Making Progress in North America?
    Ann Surg. 2019 Oct 28. doi: 10.1097/SLA.0000000000003628.
    PubMed     Abstract available


  116. GIRGIS MD, Zenati MS, King JC, Hamad A, et al
    Oncologic Outcomes After Robotic Pancreatic Resections Are Not Inferior to Open Surgery.
    Ann Surg. 2019 Oct 28. doi: 10.1097/SLA.0000000000003615.
    PubMed     Abstract available


  117. HACKERT T, Klaiber U, Buchler MW
    Response: Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer" What Is Good for the Surgeon Is Just as Good for the Patient? The Case of Unresectable Pancreatic Cancer After
    Ann Surg. 2019 Oct 22. doi: 10.1097/SLA.0000000000003652.
    PubMed    


  118. SHI Y, Wang W, Qiu W, Zhao S, et al
    Learning Curve From 450 Cases of Robot-Assisted Pancreaticoduocectomy in a High-Volume Pancreatic Center: Optimization of Operative Procedure and a Retrospective Study.
    Ann Surg. 2019 Oct 22. doi: 10.1097/SLA.0000000000003664.
    PubMed     Abstract available


  119. UEMURA J, Okano K, Oshima M, Suto H, et al
    Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors.
    Ann Surg. 2019 Oct 9. doi: 10.1097/SLA.0000000000003624.
    PubMed     Abstract available


  120. SANDINI M, Paiella S, Cereda M, Angrisani M, et al
    Perioperative Interstitial Fluid Expansion Predicts Major Morbidity Following Pancreatic Surgery: Appraisal by Bioimpedance Vector Analysis.
    Ann Surg. 2019 Oct 4. doi: 10.1097/SLA.0000000000003536.
    PubMed     Abstract available


    September 2019
  121. MAZZAFERRO V, Virdis M, Sposito C, Cotsoglou C, et al
    Permanent Pancreatic Duct Occlusion With Neoprene-based Glue Injection After Pancreatoduodenectomy at High Risk of Pancreatic Fistula: A Prospective Clinical Study.
    Ann Surg. 2019 Sep 26. doi: 10.1097/SLA.0000000000003514.
    PubMed     Abstract available


  122. PULVIRENTI A, Javed AA, Landoni L, Jamieson NB, et al
    Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors.
    Ann Surg. 2019 Sep 24. doi: 10.1097/SLA.0000000000003579.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: